Tumor Type

Australia
Ovarian Cancer - Serous cystadenocarcinoma
Funding Organizations
Australia: National Health and Medical Research Council
Australia: Queensland State Government
Australia: University of Queensland
Australia: Institute for Molecular Bioscience
Research Organizations
Australia: Australian Ovarian Cancer Study
Australia: Peter MacCallum Cancer Centre
Australia: Queensland Centre for Medical Genomics
Australia: Institute for Molecular Bioscience
Research Activities
Publication Policy
1:   ICGC Goals, Structure, Policies and Guidelines Section E.3 - Publication Policy HTML 
2:   Template Letters to Facilitate Communications HTML 
to ensure appropriate dialogue between data users and generators and for authors to contact ICGC members and editors
3:   QCMG Project Specific Moratorium HTML 
Clinic & Pathology
Australia: Australian Ovarian Cancer Study
Peter MacCallum Cancer Centre
Sequencing & Analysis
Australia: Institute for Molecular Bioscience
Complementary Studies
Australia: Institute for Molecular Bioscience
Peter MacCallum Cancer Centre
Data Storage, Analysis & Management
Australia: Institute for Molecular Bioscience
Peter MacCallum Cancer Centre
Project Summary

The primary aims sequence largely paired primary and recurrent ovarian tumors primarily drawn from a population based cohort study, the Australian Ovarian Cancer Study. The studies will define the somatic genomic abnormalities in primary ovarian tumours and insights into the molecular drivers of primary and acquired platinum resistance.

Principal Investigators

Institute for Molecular Bioscience
• Sean M. Grimmond (overall lead)
• David Miller
• Conrad Leonard
• Nicola Waddell
• Peter Wilson
• John V. Pearson
• Karin Kassahn

Peter MacCallum Cancer Centre
• David Bowtell (ovarian cancer lead)
• Dariush Etemadmoghadam

Westmead Millennium Institute for Medical Research
• Anna de Fazio

Queensland Institute for Medical Research
• Adèle Green
• Georgia Chenevix-Trench
• Penelope Webb
• David Whiteman
• David Purdie

Lead Jurisdiction